AAAAAA

   
Results: 1-14 |
Results: 14
RANDOMIZED TRIAL OF R-METHU GRANULOCYTE-COLONY-STIMULATING FACTOR IN AN INTENSIVE TREATMENT FOR T-CELL LEUKEMIA AND ADVANCED-STAGE LYMPHOBLASTIC LYMPHOMA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY
Authors: LAVER J AMYLON M DESAI S LINK M SCHWENN M MAHMOUD H SHUSTER J
Citation: J. Laver et al., RANDOMIZED TRIAL OF R-METHU GRANULOCYTE-COLONY-STIMULATING FACTOR IN AN INTENSIVE TREATMENT FOR T-CELL LEUKEMIA AND ADVANCED-STAGE LYMPHOBLASTIC LYMPHOMA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP PILOT-STUDY, Journal of clinical oncology, 16(2), 1998, pp. 522-526
SHORTENED SURVIVAL AFTER RELAPSE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS WITH P16 P15 DELETIONS/
Authors: DICCIANNI MB BATOVA A YU J VU T PULLEN J AMYLON M POLLOCK BH YU AL
Citation: Mb. Diccianni et al., SHORTENED SURVIVAL AFTER RELAPSE IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA PATIENTS WITH P16 P15 DELETIONS/, Leukemia research, 21(6), 1997, pp. 549-558
INCREASED FREQUENCY OF EXPRESSION OF ELEVATED DIHYDROFOLATE-REDUCTASEIN T-CELL VERSUS B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN
Authors: MATHERLY LH TAUB JW WONG SC SIMPSON PM EKIZIAN R BUCK S WILLIAMSON M AMYLON M PULLEN J CAMITTA B RAVINDRANATH Y
Citation: Lh. Matherly et al., INCREASED FREQUENCY OF EXPRESSION OF ELEVATED DIHYDROFOLATE-REDUCTASEIN T-CELL VERSUS B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN, Blood, 90(2), 1997, pp. 578-589
ECONOMIC-ANALYSIS OF G-CSF USE WITH INTENSIVE TREATMENT FOR PEDIATRICLYMPHOMA AND T-CELL LEUKEMIA
Authors: PAJEAU TS LANE D BENNETT CL LAND V AMYLON M LAVER JH
Citation: Ts. Pajeau et al., ECONOMIC-ANALYSIS OF G-CSF USE WITH INTENSIVE TREATMENT FOR PEDIATRICLYMPHOMA AND T-CELL LEUKEMIA, Blood, 90(10), 1997, pp. 316-316
ALLOGENEIC STEM-CELL TRANSPLANTATION FROM HLA-HAPLOIDENTICAL RELATIVES AS TREATMENT FOR CHILDREN WITH HEMATOLOGIC MALIGNANCY - A PHASE I IISTUDY USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) THAT HAVE UNDERGONE CD34 SELECTION FOLLOWED BY CD2 DEPLETION/
Authors: YEAGER AM AMYLON M WAGNER J CALDERWOOD S ANASETTI C SENDER L JACOBS C BENYUNES M
Citation: Am. Yeager et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FROM HLA-HAPLOIDENTICAL RELATIVES AS TREATMENT FOR CHILDREN WITH HEMATOLOGIC MALIGNANCY - A PHASE I IISTUDY USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) THAT HAVE UNDERGONE CD34 SELECTION FOLLOWED BY CD2 DEPLETION/, Blood, 90(10), 1997, pp. 958-958
MARROW TRANSPLANTATION FROM UNRELATED DONORS (UDT) IN PATIENTS WITH APLASTIC-ANEMIA (AA) WHO HAVE FAILED IMMUNOSUPPRESSIVE THERAPY
Authors: DEEG HJ AMYLON M COLLINS R CHAUNCY T BURDACH S KAIZER H GELLER RB COPELAN E STORB R ANASETTI C HOWE C MUELLER BA
Citation: Hj. Deeg et al., MARROW TRANSPLANTATION FROM UNRELATED DONORS (UDT) IN PATIENTS WITH APLASTIC-ANEMIA (AA) WHO HAVE FAILED IMMUNOSUPPRESSIVE THERAPY, Experimental hematology, 24(9), 1996, pp. 652-652
PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA WITH EOSINOPHILIA AND T(5-14)
Authors: GEAGHAN S AMYLON M LINK M
Citation: S. Geaghan et al., PEDIATRIC ACUTE LYMPHOBLASTIC-LEUKEMIA WITH EOSINOPHILIA AND T(5-14), Blood, 88(10), 1996, pp. 3348-3348
LONG-TERM COMPLICATIONS OF BONE-MARROW TRANSPLANTATION (BMT) IN IRON-LOADED PATIENTS
Authors: ANDERSON R BASRAN R BLANCHETTE N KLEIN N MUROFF A AMYLON M BRITTENHAM GM MENTZER W VICHINSKY EP OLIVIERI NF
Citation: R. Anderson et al., LONG-TERM COMPLICATIONS OF BONE-MARROW TRANSPLANTATION (BMT) IN IRON-LOADED PATIENTS, Blood, 88(10), 1996, pp. 1037-1037
BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/
Authors: ODONNELL MR LONG GD PARKER PM NILAND J NADEMANEE A AMYLON M CHAO N NEGRIN RS SCHMIDT GM SLOVAK ML SMITH EP SNYDER DS STEIN AS TRAWEEK T BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/, Journal of clinical oncology, 13(12), 1995, pp. 2973-2979
DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITHT-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BASH RO HALL S TIMMONS CF CRIST WM AMYLON M SMITH RG BAER R
Citation: Ro. Bash et al., DOES ACTIVATION OF THE TAL1 GENE OCCUR IN A MAJORITY OF PATIENTS WITHT-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Blood, 86(2), 1995, pp. 666-676
HIGH-FREQUENCY ALTERATIONS OF THE P16 AND P15, BUT NOT P18, CDK INHIBITORS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: YU AL DICCIANNI MB BATOVA A VU T PULLEN J AMYLON M POLLOCK B YU J
Citation: Al. Yu et al., HIGH-FREQUENCY ALTERATIONS OF THE P16 AND P15, BUT NOT P18, CDK INHIBITORS IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 86(10), 1995, pp. 1057-1057
RECENT ADVANCES IN THERAPY OF HIGH-GRADE T-CELL AND B-CELL NON-HODGKINS-LYMPHOMAS (NHL) OF CHILDHOOD
Authors: MURPHY SB AMYLON M LINK MP BOWMAN WP BRECHER M PICK T BERARD CW HUTCHINSON R SHUSTER JJ
Citation: Sb. Murphy et al., RECENT ADVANCES IN THERAPY OF HIGH-GRADE T-CELL AND B-CELL NON-HODGKINS-LYMPHOMAS (NHL) OF CHILDHOOD, Journal of cellular biochemistry, 1993, pp. 257-257
LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VENA-CAVA SYNDROME - A CASE-REPORT
Authors: MOGUL M HARTMAN G DONALDSON S GELB A LINK M AMYLON M GLADER B
Citation: M. Mogul et al., LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VENA-CAVA SYNDROME - A CASE-REPORT, Medical and pediatric oncology, 21(6), 1993, pp. 456-459
CLINICAL-FEATURES AND OUTCOME OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD WITH RESPECT TO ALTERATIONS AT THE TAL1 LOCUS - A PEDIATRIC ONCOLOGY GROUP-STUDY
Authors: BASH RO CRIST WM SHUSTER JJ LINK MP AMYLON M PULLEN J CARROLL AJ BUCHANAN GR SMITH RG BAER R
Citation: Ro. Bash et al., CLINICAL-FEATURES AND OUTCOME OF T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD WITH RESPECT TO ALTERATIONS AT THE TAL1 LOCUS - A PEDIATRIC ONCOLOGY GROUP-STUDY, Blood, 81(8), 1993, pp. 2110-2117
Risultati: 1-14 |